[go: up one dir, main page]

HK1163088A - 2,5-disubstituted arylsulfonamide ccr3 antagonists - Google Patents

2,5-disubstituted arylsulfonamide ccr3 antagonists Download PDF

Info

Publication number
HK1163088A
HK1163088A HK12103763.5A HK12103763A HK1163088A HK 1163088 A HK1163088 A HK 1163088A HK 12103763 A HK12103763 A HK 12103763A HK 1163088 A HK1163088 A HK 1163088A
Authority
HK
Hong Kong
Prior art keywords
ccr3 antagonists
disubstituted
disubstituted arylsulfonamide
arylsulfonamide ccr3
ccr3
Prior art date
Application number
HK12103763.5A
Other languages
Chinese (zh)
Inventor
Tai Wei Ly
Marie Chantal Siu-Ying Tran
Erik Dean RAAUM
Original Assignee
Axikin Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axikin Pharmaceuticals, Inc. filed Critical Axikin Pharmaceuticals, Inc.
Publication of HK1163088A publication Critical patent/HK1163088A/en

Links

Abstract

Provided herein are 2,5-disubstituted arylsulfonamides that are useful for modulating CCR3 activity, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a CCR3-mediated disorder, disease, or condition.
HK12103763.5A 2009-04-22 2010-04-21 2,5-disubstituted arylsulfonamide ccr3 antagonists HK1163088A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61/171,775 2009-04-22

Publications (1)

Publication Number Publication Date
HK1163088A true HK1163088A (en) 2012-09-07

Family

ID=

Similar Documents

Publication Publication Date Title
WO2011116161A3 (en) Arylsulfonamide ccr3 antagonists
WO2010123956A3 (en) 2,5-disubstituted arylsulfonamide ccr3 antagonists
WO2012051318A8 (en) Sulphonamide compounds and methods of making and using same
WO2009039460A3 (en) Co-administration of pimavanserin with other agents
BR112013015855A2 (en) compound, use of a compound, methods of prevention, treatment, amelioration or prophylaxis of physiological disorders or diseases, and treatment or amelioration of cosmetic indications; and, pharmaceutical composition.
PL2150530T3 (en) Substituted sulfonamide derivatives
WO2010123959A3 (en) 2,5-disubstituted arylsulfonamide ccr3 antagonists
HK1208678A1 (en) 3,5-diaminopyrazole kinase inhibitors
WO2010123960A3 (en) Arylsulfonamide ccr3 antagonists
BRPI0511099A (en) compounds and compositions as modulators of ppar
TW200733961A (en) Diaryl urea for treating pulmonary hypertension
MX2010001243A (en) Anti-inflammatory composition.
WO2006020680A3 (en) Heterocyclic compounds as pharmaceutical agents
UA88165C2 (en) APPLICATION OF THREE-SUBSTITUTED BENZOPYRANONS $ APPLICATION OF THREE-SUBSTITUTED BENZOPYRANONES
HK1212351A1 (en) Isotopically enriched arylsulfonamide ccr3 antagonists
EP2566502A4 (en) Methods for treating or preventing cardiovascular disorders and providing cardiovascular protection
WO2009003711A3 (en) Stereoisomers of tricyclodecan-9-yl-xanthogenate
HK1163088A (en) 2,5-disubstituted arylsulfonamide ccr3 antagonists
HK1162474A (en) Arylsulfonamide ccr3 antagonists
HK1180335A (en) Arylsulfonamide ccr3 antagonists
HK1187922A (en) Salts of arylsulfonamide ccr3 antagonists
BRPI0510503A (en) compounds and compositions as cathepsin inhibitors
UA91385C2 (en) Diaryl urea for treating pulmonary hypertension
HK1136549A (en) Stereoisomers of tricyclodecan-9-yl-xanthogenate
HK1135910A (en) Treatment of respiratory chain disorders using compounds having erythropoietin or thrombopoietin activity